Raphael Pharmaceutical (RAPH) EPS (Basic) (2020 - 2024)
Raphael Pharmaceutical (RAPH) posted EPS (Basic) of -$0.1 for Q4 2024, down 506.53% sequentially from -$0.02 in Q3 2024, and down 52.25% YoY from -$0.22 in Q1 2024.
Raphael Pharmaceutical (RAPH) EPS (Basic) (2020 - 2024) Analysis & Trends
Raphael Pharmaceutical has reported EPS (Basic) for 5 years, with the latest figure at -$0.1 in Q4 2024.
- Quarterly EPS (Basic) fell 52.25% year-over-year to -$0.1 in Q4 2024, while the trailing twelve-month figure through Sep 2025 was -$0.1 (up 18.22% YoY) and the FY2025 annual result came in at -$0.17, down 1.31% from the prior year.
- EPS (Basic) fell to -$0.1 in Q4 2024 per RAPH's latest filing, from -$0.02 in the prior quarter.
- Over five years, EPS (Basic) peaked at -$0.01 in Q2 2024 and troughed at -$0.16 in Q4 2021.
- A 5-year average of -$0.05 and a median of -$0.04 in 2021 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2021 and 2024: EPS (Basic) slumped 299.61% in 2021, then jumped 61.52% in 2024.
- Over 5 years, EPS (Basic) stood at -$0.04 in 2020, then plunged by 299.61% to -$0.16 in 2021, then grew by 21.5% to -$0.13 in 2022, then jumped by 46.77% to -$0.07 in 2023, then sank by 52.25% to -$0.1 in 2024.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$0.1, -$0.02, and -$0.01 for Q4 2024, Q3 2024, and Q2 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | -0.49 |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 2.07 |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 0.45 |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 7.82 |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | -0.10 |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 1.43 |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 0.11 |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Raphael Pharmaceutical | 28.25 Mn | 28.25 Mn | - | -0.01 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -0.10 |
| Sep 30, 2024 | -0.02 |
| Jun 30, 2024 | -0.01 |
| Mar 31, 2024 | -0.03 |
| Dec 31, 2023 | -0.07 |
| Sep 30, 2023 | -0.04 |
| Jun 30, 2023 | -0.03 |
| Mar 31, 2023 | -0.02 |
| Dec 31, 2022 | -0.13 |
| Sep 30, 2022 | -0.09 |
| Jun 30, 2022 | -0.04 |
| Mar 31, 2022 | -0.01 |
| Dec 31, 2021 | -0.16 |
| Sep 30, 2021 | -0.03 |
| Jun 30, 2021 | -0.04 |
| Mar 31, 2021 | -0.03 |
| Dec 31, 2020 | -0.04 |